Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
about
Serum prolidase activity and oxidant-antioxidant status in children with chronic hepatitis B virus infectionEvaluation of the utility of serum prolidase as a marker for liver fibrosisT2 relaxation time is related to liver fibrosis severity.Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.Influence of expert-dependent variability over the performance of noninvasive fibrosis assessment in patients with chronic hepatitis C by means of texture analysis.Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?Perfusion CT imaging of the liver: review of clinical applicationsNon-invasive predictive score of fibrosis stages in chronic hepatitis C patients based on epithelial membrane antigen in the blood in combination with routine laboratory markers.A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factors.Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis.Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis--a serological evaluation.
P2860
Q21146641-7D132CB2-1B9B-40ED-8312-FB768915C320Q28239568-B62305FE-8285-45B8-8208-F66E077EF255Q30383680-37FFA48A-35FB-40AA-8BCC-919639CC4D6DQ34103693-A59A6DE9-B7A4-4868-8BB7-35DE173D1470Q34749550-365DA200-00A7-455A-9DC4-66988F321F85Q35645808-65533F1C-1A30-4A02-AE8F-BD76F17CF9F9Q36156172-998CF80A-29D2-4247-AB3A-32769EE37F29Q37897194-E5DE3B02-1A9C-419B-85B4-0446C3A97FCFQ38212261-0133CC86-B262-4516-9A83-03E2BF812BB7Q38883255-55B87085-96D1-40D7-AA1F-6C2E12016BFAQ41020416-C7C01E39-C7D1-44BE-9DB6-ADD24EBCA455Q41658253-DE8BB8B1-DAAC-4939-A4DA-197CF813EF15Q50497712-646D97FC-B805-426D-918C-45162915B702
P2860
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
@en
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
@nl
type
label
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
@en
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
@nl
prefLabel
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
@en
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
@nl
P1476
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
@en
P2093
W M Rosenberg
P304
883-900, x
P356
10.1016/J.CLD.2008.07.010
P577
2008-11-01T00:00:00Z